<i>TP53</i> and/or <i>BRCA1</i> Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer

<i>TP53</i> and/or <i>BRCA1</i> Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer

Precise biomarkers for predicting the therapeutic efficacy of molecularly targeted drugs are limited at the protein level; thus, it has been important to broadly scrutinize individual cancer driver gene mutations for effective cancer treatments. Multiplex cancer genome profiling can comprehensively...

Full description

Bibliographic Details
Main Authors: Akiko Arimura, Kazuko Sakai, Kazuhisa Kaneshiro, Takafumi Morisaki, Saori Hayashi, Kimihisa Mizoguchi, Mai Yamada, Masaya Kai, Mayumi Ono, Kazuto Nishio, Masafumi Nakamura, Makoto Kubo
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
ctDNA
<i>TP53</i>
<i>BRCA1</i>
triple-negative breast cancer
Online Access:https://www.mdpi.com/2072-6694/16/6/1184

Internet

https://www.mdpi.com/2072-6694/16/6/1184

Similar Items